BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 24/07/1997

Guidance for Industry: Changes To An Approved Application For Specified Biotechnology and Specified Synthetic Biological Products; Availability

The Food and Drug Administration (FDA) is announcing the availability of a guidance document entitled, ``Guidance for Industry: Changes To An Approved Application For Specified Biotechnology and Specified Synthetic Biological Products.'' The guidance document is intended to assist manufacturers in determining which reporting mechanism is appropriate for a change to an approved license application under the final rule ``Changes To An Approved Application,'' issued elsewhere in this issue of the Federal Register. In a separate document also published in this issue of the Federal Register, FDA is announcing the availability of a guidance document entitled, ``Guidance for Industry: Changes To An Approved Application: Biological Products,'' to assist applicants in determining how they should report changes to an approved license application for biologic products other than specified biotechnology and specified synthetic biological products under the final rule. The guidance document announced in this notice revises the draft guidance entitled, ``Draft Guidance; Changes To An Approved Application for Well-Characterized Therapeutic Recombinant DNA-Derived and Monoclonal Antibody Biotechno

Source: Federal Register — Food and Drug AdministrationOpen original release →